---
figid: PMC6335350__fnins-12-01017-g0001
figtitle: Interplay between mTOR, AB and Tau in Alzheimer's disease
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6335350
filename: fnins-12-01017-g0001.jpg
figlink: /pmc/articles/PMC6335350/figure/F1/
number: F1
caption: Interplay between mTOR, Aβ and Tau in Alzheimer's disease. mTOR is activated
  by the activation of a number of upstream components (PI3-K/Akt, GSK3, AMPK, IGF-1)
  in a sequence specific pathway. Activation of mTOR results in the activation of
  downstream components (4EBP1 and p70S6K1). Both 4EBP1 and p70S6K1 initiate their
  cascades ultimately causing hyperphosphorylation of tau, leading to the formation
  of PHF's and NFT's. mTOR leads to the accumulation of Aβ plaques by inhibiting autophagy.
  Accumulated Aβ further induces tau phosphorylation and mTOR activation. Additionally,
  Immune dysfunction, blood-brain barier dysfunction, upregulated Cdk5, and interlukins
  also contribute to AD. Formations of NFT's and Aβ plaques give rise to AD symptoms.
  IGF, Insulin Growth Factor; TSC1/TSC2, Tuberous Sclerosis Complex1/2; IRS, Insulin
  Receptor Substrate; IR, Insulin Resistance; p70S6K1, p70 ribosomal S6 Kinase1; PHF's,
  Paired Helical Filaments; NFT's, Neurofibrillary Tangles, p, phosphorylation; p-p,
  hyperphosphorylation; PI3-K, phosphoinositide 3-kinase; AMPK, AMP-activated protein
  kinase; GSK3, Glycogen Synthase Kinase.
papertitle: 'Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer''s
  Development.'
reftext: Zeba Mueed, et al. Front Neurosci. 2018;12:1017.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7594063
figid_alias: PMC6335350__F1
figtype: Figure
redirect_from: /figures/PMC6335350__F1
ndex: b2f0ed38-df21-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6335350__fnins-12-01017-g0001.html
  '@type': Dataset
  description: Interplay between mTOR, Aβ and Tau in Alzheimer's disease. mTOR is
    activated by the activation of a number of upstream components (PI3-K/Akt, GSK3,
    AMPK, IGF-1) in a sequence specific pathway. Activation of mTOR results in the
    activation of downstream components (4EBP1 and p70S6K1). Both 4EBP1 and p70S6K1
    initiate their cascades ultimately causing hyperphosphorylation of tau, leading
    to the formation of PHF's and NFT's. mTOR leads to the accumulation of Aβ plaques
    by inhibiting autophagy. Accumulated Aβ further induces tau phosphorylation and
    mTOR activation. Additionally, Immune dysfunction, blood-brain barier dysfunction,
    upregulated Cdk5, and interlukins also contribute to AD. Formations of NFT's and
    Aβ plaques give rise to AD symptoms. IGF, Insulin Growth Factor; TSC1/TSC2, Tuberous
    Sclerosis Complex1/2; IRS, Insulin Receptor Substrate; IR, Insulin Resistance;
    p70S6K1, p70 ribosomal S6 Kinase1; PHF's, Paired Helical Filaments; NFT's, Neurofibrillary
    Tangles, p, phosphorylation; p-p, hyperphosphorylation; PI3-K, phosphoinositide
    3-kinase; AMPK, AMP-activated protein kinase; GSK3, Glycogen Synthase Kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt
  - SNF4Agamma
  - AMPKalpha
  - sgg
  - gig
  - Tsc1
  - Rheb
  - PRAS40
  - Mtor
  - Tor
  - sle
  - sel
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Thor
  - Crtc
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - tau
  - Is
  - ab
  - Appl
  - P-25
  - Cdk5alpha
  - DCTN5-p25
  - ad
  - ATPsynbeta
  - Atpalpha
  - Amph
  - Cdk5
  - PLK3
  - AKT1
  - AKT2
  - AKT3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GSK3A
  - GSK3B
  - IGF1
  - TSC2
  - IRS1
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - IGF1R
  - AKT1S1
  - MTOR
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - EIF4EBP1
  - RPTOR
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MAPT
  - APP
  - SUCLA2
  - LCN2
  - CDK5R1
  - TPPP
  - TMED9
  - ATP8A2
  - APRT
  - MFAP1
  - CDK5
  - tyr
  - ser
  - ATP
  - AMP
  - SLE
  - Skin Cancer
  - P-P-Tau  PHFs
  - Alzheimers Disease
  - AD
---
